Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03555 | 33957803 | Exp Biol Med (Maywood) | Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. | 2021 | Details |
| A03567 | 33951744 | Andrologia | Predicting risk of erectile dysfunction in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03579 | 33946843 | Microorganisms | Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. | 2021 | Details |
| A03581 | 33946154 | Microorganisms | High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. | 2021 | Details |
| A03584 | 33942524 | Pediatr Obes | Association between ectopic pancreatic and hepatic fat and metabolic risk factors in children with non-alcoholic fatty liver disease. | 2021 | Details |
| A03585 | 33941551 | BMJ Open Diabetes Res Care | Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels. | 2021 | Details |
| A03594 | 33938630 | Liver Int | Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis. | 2021 | Details |
| A03633 | 33923817 | Int J Mol Sci | Role of Insulin Resistance in MAFLD. | 2021 | Details |
| A03657 | 33917919 | Cancers (Basel) | The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. | 2021 | Details |
| A03668 | 33913734 | J Altern Complement Med | Chinese Herbal Medicine Decreases Incidence of Cirrhosis in Patients with Non-Alcoholic Fatty Liver Disease in Taiwan: A Propensity Score-Matched Cohort Study. | 2021 | Details |
| A03696 | 33899670 | Int J Food Sci Nutr | Dietary isoflavones intake is inversely associated with non-alcoholic fatty liver disease, hyperlipidaemia and hypertension. | 2021 | Details |
| A03727 | 33889132 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes. | 2021 | Details |
| A03728 | 33889015 | Int J Gen Med | Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03823 | 33856246 | Expert Opin Emerg Drugs | Emerging synthetic drugs for the treatment of liver cirrhosis. | 2021 | Details |
| A03835 | 33853719 | Nutr Metab Cardiovasc Dis | The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease. | 2021 | Details |
| A03854 | 33845089 | J Lipid Res | The lipidome in nonalcoholic fatty liver disease: actionable targets. | 2021 | Details |
| A03886 | 33833347 | Sci Rep | Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis. | 2021 | Details |
| A03921 | 33816145 | World J Transplant | Noninvasive markers of liver steatosis and fibrosis after liver transplantation - Where do we stand? | 2021 | Details |
| A03975 | 33804385 | J Pers Med | PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center. | 2021 | Details |
| A04037 | 33780425 | MEDICC Rev | Non-Alcoholic Fatty Liver Disease in Cuba. | 2021 | Details |
| A04039 | 33780129 | Am J Transplant | Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications. | 2021 | Details |
| A04047 | 33776934 | Front Endocrinol (Lausanne) | The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study. | 2021 | Details |
| A04068 | 33771699 | Pharmacol Res | Epigenetics in NAFLD/NASH: Targets and therapy. | 2021 | Details |
| A04092 | 33762835 | Diabetes Metab Syndr Obes | Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. | 2021 | Details |
| A04149 | 33740939 | BMC Endocr Disord | Hemoglobin concentration is associated with the incidence of metabolic syndrome. | 2021 | Details |
| A04152 | 33739984 | PLoS One | Association between sarcopenia level and metabolic syndrome. | 2021 | Details |
| A04163 | 33732030 | Clin Pharmacol | Clinical Impact of Liraglutide as a Treatment of Obesity. | 2021 | Details |
| A04166 | 33731579 | Eur J Gastroenterol Hepatol | Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea. | 2021 | Details |
| A04190 | 33722154 | Adipocyte | Dysfunctional adiposity index as a marker of adipose tissue morpho-functional abnormalities and metabolic disorders in apparently healthy subjects. | 2021 | Details |
| A04212 | 33711631 | Clin Res Hepatol Gastroenterol | The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. | 2021 | Details |
| A04219 | 33709606 | J Gastroenterol Hepatol | Artificial intelligence in precision medicine in hepatology. | 2021 | Details |
| A04234 | 33703947 | J Appl Physiol (1985) | High fat high sucrose diet-induced dyslipidemia in guinea pigs. | 2021 | Details |
| A04252 | 33688490 | Can J Gastroenterol Hepatol | Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements. | 2021 | Details |
| A04259 | 33685807 | Dig Liver Dis | Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. | 2021 | Details |
| A04288 | 33676874 | Surg Obes Relat Dis | The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis. | 2020 | Details |
| A04348 | 33653293 | BMC Gastroenterol | Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study. | 2021 | Details |
| A04377 | 33642355 | Saudi J Gastroenterol | The effect of hepatic steatosis on COVID-19 severity: Chest computed tomography findings. | 2021 | Details |
| A04411 | 33628759 | Can J Gastroenterol Hepatol | Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements. | 2021 | Details |
| A04422 | 33622266 | BMC Gastroenterol | The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C. | 2021 | Details |
| A04494 | 33596964 | J Med Case Rep | Hemochromatosis, alcoholism and unhealthy dietary fat: a case report. | 2021 | Details |
| A04512 | 33592910 | Medicine (Baltimore) | Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis. | 2021 | Details |
| A04522 | 33588049 | Free Radic Biol Med | Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signaling. | 2021 | Details |
| A04542 | 33584134 | J Med Biochem | The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. | 2021 | Details |
| A04547 | 33583033 | Eur J Clin Invest | Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches. | 2021 | Details |
| A04571 | 33577591 | PLoS Comput Biol | From heterogeneous healthcare data to disease-specific biomarker networks: A hierarchical Bayesian network approach. | 2021 | Details |
| A04581 | 33573745 | J Am Coll Cardiol | Leptin in Leanness and Obesity: JACC State-of-the-Art Review. | 2021 | Details |
| A04597 | 33568925 | Diabetes Metab Syndr Obes | The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity. | 2021 | Details |
| A04598 | 33568794 | Nat Rev Gastroenterol Hepatol | Therapeutic pipeline in nonalcoholic steatohepatitis. | 2021 | Details |
| A04627 | 33558081 | Mol Genet Metab | US-FLI score - Is it possible to predict the steatosis grade with an ultrasonographic score? | 2021 | Details |
| A04637 | 33555168 | Clin Transl Gastroenterol | Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation. | 2021 | Details |
| A04641 | 33554097 | JHEP Rep | Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction. | 2020 | Details |
| A04668 | 33546191 | Biomedicines | Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. | 2021 | Details |
| A04670 | 33546130 | Nutrients | Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04681 | 33544313 | Hepatol Int | Regression of portal hypertension: underlying mechanisms and therapeutic strategies. | 2021 | Details |
| A04692 | 33539004 | Hepatol Int | The metabolic profiles and body composition of lean metabolic associated fatty liver disease. | 2021 | Details |
| A04703 | 33535211 | Dig Dis | NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea. | 2021 | Details |
| A04706 | 33534958 | ESC Heart Fail | Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues. | 2021 | Details |
| A04737 | 33520498 | Cureus | Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study. | 2020 | Details |
| A04765 | 33512644 | Hepatol Int | Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study. | 2021 | Details |
| A04768 | 33511287 | Clin Exp Hepatol | Comparison of knowledge and awareness between consultant physicians and resident doctors about non-alcoholic fatty liver disease. | 2020 | Details |
| A04773 | 33511092 | Front Pediatr | Childhood and Adolescent Obesity: A Review. | 2021 | Details |
| A04779 | 33509116 | BMC Gastroenterol | Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease. | 2021 | Details |
| A04845 | 33486379 | Comput Biol Med | A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection? | 2021 | Details |
| A04867 | 33475584 | J Pak Med Assoc | Association of apoptotic marker cytokeratin18 with blood pressure in nonalcoholic fatty liver disease patients. | 2020 | Details |
| A04890 | 33465383 | Complement Ther Med | Effects of artichoke on blood pressure: A systematic review and meta-analysis. | 2021 | Details |
| A04929 | 33445827 | Epidemiol Health | Renal hyperfiltration, fatty liver index, and the hazards of all-cause and cardiovascular mortality in Finnish men. | 2020 | Details |
| A04940 | 33442452 | World J Hepatol | Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver. | 2020 | Details |
| A04945 | 33441894 | Sci Rep | Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring. | 2021 | Details |
| A04955 | 33437906 | Hepatol Commun | Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma. | 2020 | Details |
| A04961 | 33437782 | Ann Transl Med | Clinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes. | 2020 | Details |
| A04967 | 33435558 | Molecules | Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice. | 2021 | Details |
| A04968 | 33435509 | Biomedicines | The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. | 2021 | Details |
| A05016 | 33409407 | Transl Gastroenterol Hepatol | Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis. | 2021 | Details |
| A05020 | 33408593 | EXCLI J | Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction. | 2020 | Details |
| A05038 | 33398223 | J Clin Exp Hepatol | Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? | 2020 | Details |
| A05048 | 33395403 | Am J Case Rep | A Case of Hypopituitarism Complicated by Non-Alcoholic Steatohepatitis and Severe Pulmonary Hypertension. | 2021 | Details |
| A05083 | 33384552 | World J Gastroenterol | Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study. | 2020 | Details |
| A05087 | 33382757 | PLoS One | Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease. | 2020 | Details |
| A05102 | 33376110 | BMJ Open Gastroenterol | Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. | 2020 | Details |
| A05116 | 33370454 | J Gastroenterol Hepatol | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes. | 2021 | Details |
| A05130 | 33362390 | World J Gastroenterol | Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis. | 2020 | Details |
| A05181 | 33345307 | Hepatology | Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. | 2021 | Details |
| A05228 | 33331479 | Arq Gastroenterol | PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS. | 2021 | Details |
| A05278 | 33315911 | PLoS One | The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension. | 2020 | Details |
| A05286 | 33312424 | World J Hepatol | Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis. | 2020 | Details |
| A05298 | 33309070 | Clin Investig Arterioscler | Approach to the cardiometabolic continuum. Narrative description. | 2020 | Details |
| A05305 | 33307138 | J Hepatol | Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. | 2020 | Details |
| A05321 | 33303564 | Gut | Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. | 2020 | Details |
| A05340 | 33296704 | Diabetes Metab | NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. | 2020 | Details |
| A05394 | 33272125 | Stroke | Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events. | 2020 | Details |
| A05490 | 33235107 | Medicine (Baltimore) | Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China. | 2020 | Details |
| A05495 | 33233601 | Diagnostics (Basel) | Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis. | 2020 | Details |
| A05506 | 33225408 | Obes Surg | Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis. | 2020 | Details |
| A05507 | 33224584 | Am J Cardiovasc Dis | Sex differences in cardiovascular diseases and associated risk factors in non-alcoholic steatohepatitis. | 2020 | Details |
| A05511 | 33222473 | Rev Esp Enferm Dig | Overall clinical and economic impact of non-alcoholic fatty liver disease. | 2021 | Details |
| A05589 | 33197971 | J Paediatr Child Health | Liver disease in the older child. | 2020 | Details |
| A05619 | 33186403 | PLoS One | Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients. | 2020 | Details |
| A05667 | 33166436 | Arch Endocrinol Metab | Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease: correlation with albumin/creatinine ratio. | 2020 | Details |
| A05676 | 33163950 | JHEP Rep | NAFLD and liver transplantation: Disease burden, current management and future challenges. | 2020 | Details |
| A05740 | 33136722 | Eur J Gastroenterol Hepatol | Risk factors and characteristics associated with nonalcoholic fatty liver disease in patients with ischemic colitis. | 2021 | Details |